Woodford-backed Prothena targeted by short seller Kerrisdale

LONDON (Reuters) - Hedge fund Kerrisdale Capital has taken a short position on drugmaker Prothena, a company backed by UK investor Neil Woodford, calling it "the next big biotech blowup".